NCT05951179 2026-01-27
ADVANCED-2
Protara Therapeutics
Phase 2 Recruiting
Clinical Trials
5 trialsNCT07283835 2026-01-21
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Lepu Biopharma Co., Ltd.
Phase 2 Recruiting
NCT04387461 2024-09-25
CORE-001
CG Oncology, Inc.
Phase 2 Completed
NCT01731652 2015-02-10
Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
Telormedix SA
Phase 2 Completed
NCT00141531 2012-06-14
Phase II Trial of EOquin in High-risk Superficial Bladder Cancer
Spectrum Pharmaceuticals, Inc
Phase 2 Completed